Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults
The Journal of infection (2022) - Comments
pubmed: 35718205  doi: 10.1016/j.jinf.2022.06.009  issn: 0163-4453  issn: 1532-2742 

Rajeka Lazarus, Christian Taucher, Claire Brown, Irena Čorbic Ramljak, Leon Danon, Katrin Dubischar, Christopher J.A. Duncan, Susanne Eder-Lingelbach, Saul N. Faust, Christopher Green, Karishma Gokani, Romana Hochreiter, Johanna Kellett Wright, Dowan Kwon, Alexander Middleditch, Alasdair P.S. Munro, Kush Naker, Florentina Penciu, David Price, Benedicte Querton